Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

Vertex Pharmaceuticals Inc. (VRTX) announced a profit for second quarter that fell from the same period last year.

The company's profit totaled $67 million, or $0.26 per share. This compares with $837 million, or $3.18 per share, in last year's second quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $811 million or $3.11 per share for the period.

Analysts had expected the company to earn $2.28 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 17.8% to $1.79 billion from $1.52 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q2): $811 Mln. vs. $687 Mln. last year.
-EPS (Q2): $3.11 vs. $2.61 last year.
-Analysts Estimate: $2.28
-Revenue (Q2): $1.79 Bln vs. $1.52 Bln last year.

Full year revenue guidance: $7.2 - $7.4 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT